Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral fluconazole versus oral terbinafine for moderate to severe seborrheic dermatitis
IRCT201102205871N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluconazole and Terbinafine in seborrheic dermatitis (SD) (2 arms), sponsored by Guilan University of Medical Sciences. Started Sep 2008; status: completed.
02
Drugs
fluconazoleTerbinafine
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on IRCT201102205871N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201102205871N1.